Divi Towers
1-72/23(P)/DIVIS/303 Cyber Hills Gachibowli
Hyderabad 500032
India
91 40 6696 6300
https://www.divislabs.com
Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 9,741
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Kiran Satchandra Divi B. Pharm., M.Pharm | CEO & Whole-Time Director | 227.5M | N/A | 1976 |
Mr. Venkata Ramana Nimmagadda B.Sc.(Chem) | Executive Director | 331.3M | N/A | 1958 |
Dr. Murali Krishna Prasad Divi M. Pharm, Ph.D. | MD & Executive Director | 640.6M | N/A | 1951 |
Dr. Devendra Rao Sureddy M.Sc. | Whole-Time Director (Manufacturing) | 22.58M | N/A | 1962 |
Ms. Nilima Prasad Divi | Whole-time Director, Chief Control Officer & Director of Commercial | 227.4M | N/A | 1983 |
Mr. L. Kishore Babu B.Com, FCMA, FICWA | Chief Financial Officer | N/A | N/A | 1952 |
Mr. L. Ramesh Babu LLB, M.Com, MBA | VP of Procurement & Chief Information Officer | N/A | N/A | 1957 |
Mr. M. Satish Choudhury | Company Secretary & Compliance Officer | N/A | N/A | N/A |
Mr. Satya Prakash Divi B.Tech (Mech), MBA, MS (CIS) | Vice President of Sales, Marketing & Logistics | N/A | N/A | 1977 |
Mr. Y. T. S. Prasad B.E. | Global Quality Head | N/A | N/A | 1969 |
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.
Divi's Laboratories Limited’s ISS Governance QualityScore as of October 1, 2024 is 2. The pillar scores are Audit: 10; Board: 1; Shareholder Rights: 1; Compensation: 1.